Top Industry Leaders in the Absorbable Heart Stent Market
Latest Absorbable Heart Stent Companies Updates:
Abbott: Received U.S. FDA approval in June 2021 for its XIENCE family of stents with one-month (as short as 28 days) DAPT labeling for high bleeding risk (HBR) patients. This was also approved in Europe with the shortest DAPT indication globally.
Biotronik: Gained U.S. FDA approval in September 2021 for its Orsiro Mission bioabsorbable polymer coronary drug-eluting stent system (BP-DES).
Ossum Healcare: A start-up developing stents based on bioresorbable magnesium, raised US$ 3 million in a funding round in September 2023.
Lepu Medical: A Chinese medical device company, received NMPA approval in December 2023 for its Absorbable Coronary Stent System with Sirolimus Eluting Bioabsorbable Polymer.
List of Absorbable Heart Stent Key companies in the market:
- Boston Scientific Corporation
- Braun Melsungen AG
- Abbott Laboratories
- Elixir Medical Corporation
- Medtronic
- Meril Life Sciences Pvt. Ltd.
- Biotronik
- Kyoto Medical Planning Co. Ltd.
- REVA Medical Inc.
- Terumo Medical Corporation